iifl-logo-icon 1

Dr Lal Pathlabs Ltd Share Price

2,990.15
(1.33%)
Jul 15, 2024|01:09:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,975
  • Day's High3,055
  • 52 Wk High2,998.85
  • Prev. Close2,950.85
  • Day's Low2,955
  • 52 Wk Low1,943.7
  • Turnover (lac)10,555.16
  • P/E64.12
  • Face Value10
  • Book Value227.56
  • EPS46.01
  • Mkt. Cap (Cr.)24,961.88
  • Div. Yield0.61
Loading...
  • Open2,955.2
  • Day's High3,056.5
  • Spot2,995.3
  • Prev. Close2,959.35
  • Day's Low2,954.6
  • ViewLong BuildUp
  • Market Lot300
  • OI(Chg %)46,200 (4.26%)
  • Roll Over%0.42
  • Roll Cost1.17
  • Traded Vol.6,86,400 (210.87%)
View More Futures

Dr Lal Pathlabs Ltd KEY RATIOS

Sector

Healthcare

Open

2,975

Prev. Close

2,950.85

Turnover(Lac.)

10,555.16

Day's High

3,055

Day's Low

2,955

52 Week's High

2,998.85

52 Week's Low

1,943.7

Book Value

227.56

Face Value

10

Mkt Cap (₹ Cr.)

24,961.88

P/E

64.12

EPS

46.01

Divi. Yield

0.61

Dr Lal Pathlabs Ltd Corporate Action

10 May 2024

12:00 AM

Dividend

Dividend Amount: 6

Record Date: 10 Jun, 2024

arrow

3 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

10 May 2024

12:00 AM

AGM

Announcement Date: 10 May, 2024

arrow

Dr Lal Pathlabs Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dr Lal Pathlabs Ltd SHAREHOLDING SNAPSHOT

15 Jul, 2024|01:32 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 2.03%

Foreign: 2.02%

Indian: 52.57%

Non-Promoter- 38.14%

Institutions: 38.13%

Non-Institutions: 6.96%

Custodian: 0.30%

Share Price

Dr Lal Pathlabs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

83.48

83.37

83.35

83.35

Preference Capital

0

0

0

0

Reserves

1,816.18

1,606.5

1,388.77

1,133.74

Net Worth

1,899.66

1,689.87

1,472.12

1,217.09

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

1,872.7

1,490.55

1,273.59

1,024.04

yoy growth (%)

25.63

17.03

24.36

16.12

Raw materials

-446.31

-373.9

-286.86

-219.31

As % of sales

23.83

25.08

22.52

21.41

Employee costs

-320.22

-257.43

-232.06

-175.08

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

459.39

374.04

302.75

255.31

Depreciation

-75.31

-69.77

-68

-31.04

Tax paid

-115.34

-93.93

-79.57

-87.33

Working capital

-358.09

332.24

134.44

87.45

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

25.63

17.03

24.36

16.12

Op profit growth

25.24

24.27

28.21

11.1

EBIT growth

25.47

22.51

23.92

10.42

Net profit growth

22.82

25.5

32.85

10.16

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

2,226.6

2,016.9

2,087.4

1,581.3

1,330.4

Excise Duty

0

0

0

0

0

Net Sales

2,226.6

2,016.9

2,087.4

1,581.3

1,330.4

Other Operating Income

0

0

0

0

0

Other Income

69.2

41.7

52.5

51.3

55

Dr Lal Pathlabs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,353.9

90.491,355.74238.80.091,894.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

900.5

127.2987,467.26241.770.17610.1179.02

Fortis Healthcare Ltd

FORTIS

480.4

292.7136,241.7768.330.21307.48120.36

Global Health Ltd

MEDANTA

1,212.35

90.2932,533.792.240578.65106.09

Narayana Hrudayalaya Ltd

NH

1,215.65

58.5624,856.4158.090.33846.3190.04

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Dr Lal Pathlabs Ltd

Management

Register Office

Registrar Office

Executive Chairman

Arvind Lal

Whole-time Director

Vandana Lal

Non Executive Director

Archana Lal Erdmann

Managing Director

Om Prakash Manchanda

Non Executive Director

Rahul Sharma

Independent Director

Somya Satsangi

Independent Director

Rohit Bhasin

Independent Director

Arun Duggal

Independent Director

Gurinder Singh Kalra

Independent Director

RAJIT MEHTA

Company Sec. & Compli. Officer

Vinay Gujral

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres. Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.Presently, the Company is engaged the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company has built a national, hub and spoke network that includes its National Reference Laboratory in New Delhi, Regional Reference Lab in Kolkata and 371 other clinical laboratories, 5,102 patient service centers and 10,938 pickup points as of 31 March 2023. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. Apart from these, the catalogue of services includes 481 test panels, 2763 pathology tests and 1947 radiology and cardiology tests.Late Dr. Major S.K. Lal, commenced the business of providing pathology services and maintaining a blood bank in the year 1949 through sole propriet
Read More

Company FAQs

What is the Dr Lal Pathlabs Ltd share price today?

Down Arrow

The Dr Lal Pathlabs Ltd shares price on N/A is Rs.₹2986.95 today.

What is the Market Cap of Dr Lal Pathlabs Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Lal Pathlabs Ltd is ₹24935.16 Cr. as of 15 Jul ‘24

What is the PE and PB ratio of Dr Lal Pathlabs Ltd?

Down Arrow

The PE and PB ratios of Dr Lal Pathlabs Ltd is 64.12 and 12.96 as of 15 Jul ‘24

What is the 52 Week High and Low of Dr Lal Pathlabs Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Dr Lal Pathlabs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dr Lal Pathlabs Ltd is ₹1943.2 and ₹2996 as of 15 Jul ‘24

What is the CAGR of Dr Lal Pathlabs Ltd?

Down Arrow

Dr Lal Pathlabs Ltd's CAGR for 5 Years at 22.39%, 3 Years at -5.68%, 1 Year at 23.90%, 6 Month at 20.23%, 3 Month at 25.06% and 1 Month at 7.19%.

What is the shareholding pattern of Dr Lal Pathlabs Ltd?

Down Arrow

The shareholding pattern of Dr Lal Pathlabs Ltd is as follows:
Promoters - 54.60 %
Institutions - 38.13 %
Public - 6.96 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.